The library currently houses over 950 master English instruments, with roughly 1,000 of the available translations already paired with version-specific certificates and full submission documentation. By storing these assets at the instrument-version level rather than the study level, the company allows sponsors to deploy validated content immediately without repeating linguistic reviews or certification workflows. This shift addresses a persistent bottleneck that frequently stalls the startup phase of global research.
Signant Health Expands Translation Library to Speed Clinical Trials
Clinical trial delays often hinge on the slow, iterative process of translating patient assessment instruments for international sites. Philadelphia-based Signant Health has now surpassed 9,000 pre-validated translations in its global eCOA library, effectively removing the traditional commissioning cycle for sponsors launching multi-regional studies.
Sanjiv Waghmare, chief product officer at Signant, noted that this repository allows teams to resolve translation requirements even before a study protocol is finalized. The library currently offers the deepest coverage in oncology, dermatology, and central nervous system research, with new validated instruments added continuously to support the company’s broader clinical evidence generation suite.
Comments (0)
No comments yet. Be the first!